ArticleeGastroenterology2026

Plasma cell-CD8+ T cell co-enrichment distinguishes immunotherapy-responsive hepatocellular carcinoma subtypes.

Aryan Neupane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.